Evidence map›Paper›PMID 32468301›Full record

ReviewBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz2020

[Organisational and staff requirements for antimicrobial stewardship activities in hospitals : Position paper of the Commission on Anti-Infectives, Resistance and Therapy (Commission ART) at the Robert Koch Institute, with advice from professional associations].

Bundesverband Deutscher Krankenhausapotheker e. V. (ADKA), Deutsche Gesellschaft für Hygiene und Mikrobiologie e. V. (DGHM), Deutsche Gesellschaft für Infektiologie e. V. (DGI), Deutsche Gesellschaft für Krankenhaushygiene e. V. (DGKH), Deutsche Gesellschaft für Pädiatrische Infektiologie e. V. (DGPI), Kommission Antiinfektiva, Resistenz und Therapie (Kommission ART) beim Robert Koch-Institut, Paul-Ehrlich-Gesellschaft für Chemotherapie e. V. (PEG), Robert Koch-Institut, Geschäftsstelle der Kommission ART

Open access · hybridAbstract readReviewConsensus Statement
PubMed Publisher
In one paragraph

Review in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. [S3 guideline on sepsis-prevention, diagnosis, therapy, and follow-up care-update 2025].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2025
    Guideline
  2. Article
  3. Review
  4. Article
  5. Article
  6. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bundesverband Deutscher Krankenhausapotheker e. V. (ADKA)
Deutsche Gesellschaft für Hygiene und Mikrobiologie e. V. (DGHM)
Deutsche Gesellschaft für Infektiologie e. V. (DGI)
Deutsche Gesellschaft für Krankenhaushygiene e. V. (DGKH)
Deutsche Gesellschaft für Pädiatrische Infektiologie e. V. (DGPI)
Kommission Antiinfektiva, Resistenz und Therapie (Kommission ART) beim Robert Koch-Institut
Paul-Ehrlich-Gesellschaft für Chemotherapie e. V. (PEG)
Robert Koch-Institut, Geschäftsstelle der Kommission ART

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increased awareness of the rising antimicrobial resistance problem and impending loss of suitable treatment options for infectious diseases have changed patient care. Antimicrobial/antibiotic stewardship (ABS) activities aiming to optimize antimicrobial treatment were specified in international (WHO, ECDC) and national programmes and evidence-based practice guidelines. In Germany, ABS in hospitals is enshrined in the Infection Protection Act §23 and in a national guideline. The position paper presents the goals and tasks of ABS as well as the necessary organisational and staff requirements.Qualified training and education, mandates and support from hospital directors, and the provision of sufficient resources are essential prerequisites for the successful work of the ABS team. The ABS team should work hospital-wide across clinical services. Their main tasks are developing and implementing an ABS programme tailored to local needs and the conditions of the hospital, taking into account anti-infective drug prescribing, the resistance situation and case mix. Their tasks also include drafting and implementing in-house recommendations for diagnosis, prophylaxis and treatment of important infectious diseases. The ABS team should be interdisciplinary and include specially qualified doctors and pharmacists. Doctors commissioned for ABS should support this team and take the department-specific concerns into account. The document specifies a minimum ABS staff of one full-time equivalent (FTE) per 500 beds. Depending on the case mix and specialties, additional staff may be required. It proposes that there should be 0.1 FTE doctors commissioned for ABS per 100 beds.

Indexed as

Antimicrobial StewardshipPractice Guidelines as TopicAnti-Bacterial AgentsCross InfectionDrug Resistance, MicrobialGermanyHospitalsHumansAnti-Bacterial AgentsAntimicrobial stewardshipAntimicrobial stewardship teamHuman resourcesStaffing requirementsTask of antimicrobial stewardship team

Identifiers

PMID32468301
OpenAlexW3081046496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.